Compare YRD & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | YRD | MASS |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 321.4M | 265.5M |
| IPO Year | 2015 | 2020 |
| Metric | YRD | MASS |
|---|---|---|
| Price | $1.98 | $8.09 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 70.5K | ★ 256.1K |
| Earning Date | 06-11-2026 | 05-12-2026 |
| Dividend Yield | ★ 23.28% | N/A |
| EPS Growth | N/A | ★ 125.47 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $56,197,000.00 |
| Revenue This Year | N/A | $19.44 |
| Revenue Next Year | N/A | $18.63 |
| P/E Ratio | $1.86 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.58 | $4.20 |
| 52 Week High | $7.68 | $9.34 |
| Indicator | YRD | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 42.49 | 69.79 |
| Support Level | $1.88 | $7.56 |
| Resistance Level | $2.34 | $9.25 |
| Average True Range (ATR) | 0.11 | 0.46 |
| MACD | 0.03 | 0.12 |
| Stochastic Oscillator | 21.62 | 93.80 |
Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.